Nierenersatztherapie in der Intensivmedizin

ZUSAMMENFASSUNG

Neben den klassischen Indikationen für die Nierenersatztherapie (NET) gibt es eine Reihe von Spezialindikationen sowie die Möglichkeit, mit Adsorbern oder speziellen Verfahren gezielt die Homöostase in verschiedenen Krankheitsbildern wiederherzustellen. Das macht die NET auf Intensivstation zu einem spannenden und dynamischen Feld mit vielfältigen Einsatzmöglichkeiten. Aktuell fehlt für die meisten Indikationen allerdings noch eine gute Datenbasis für die Anwendung der entsprechenden Verfahren, sodass derzeit kein Einsatz in der klinischen Routine (außerhalb klinischer Studien) empfohlen werden kann.

Publication History

Article published online:
25 June 2024

• Literatur

• 1 Adeyinka A, Bashir K. Tumor Lysis Syndrome. In: StatPearls Publishing 2023 [cited 2023 Dec 5]. Im Internet. www.ncbi.nlm.nih.gov/books/NBK518985 Stand: 18.03.2024
• 2 Arnaud M, Loiselle M, Vaganay C. et al Tumor Lysis Syndrome and AKI: Beyond Crystal Mechanisms. J Am Soc Nephrol 2022; 33: 1154-1171
• 3 Anderson A, Shoulders L, James V. et al Benefit of continuous kidney replacement therapy for managing tumor lysis syndrome in children with hematologic malignancies. Front Oncol 2023; 13: 1234677
• 4 Casserly B, Phillips GS, Schorr C. et al Lactate measurements in sepsis-induced tissue hypoperfusion: results from the Surviving Sepsis Campaign database. Crit Care Med 2015; 43: 567-573
• 5 Vincent JL, Bakker J. Blood lactate levels in sepsis: in 8 questions. Curr Opin Crit Care 2021; 27: 298-302
• 6 Reis T, Ronco F, Ostermann M. Diuretics and Ultrafiltration in Heart Failure. Cardiorenal Med 2023; 13: 56-65
• 7 Cullis B, Al-Hwiesh A, Kilonzo K. et al ISPD guidelines for peritoneal dialysis in acute kidney injury: 2020 update (adults). Perit Dial Int 2021; 41: 15-31
• 8 Al Sahlawi M, Ponce D, Charytan DM. et al Peritoneal Dialysis in Critically Ill Patients: Time for a Critical Reevaluation?. Clin J Am Soc Nephrol 2023; 18: 512-520
• 9 Honore PM, Clark W. Preliminary results of the HICOSS study. Proc 10th WFSCICCM 2009. 2009 Florenz (Italien)
• 10 Joannes-Boyau O, Honoré PM, Perez P. et al High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicentre randomized controlled trial. Intensive Care Med 2013; 39: 1535-1546
• 11 Cruz BA, Ramanoelina J, Mahr A. et al Prognosis and outcome of 26 patients with systemic necrotizing vasculitis admitted to the intensive care unit. Rheumatology (Oxford) 2003; 42: 1183-1188
• 12 Payen DM, Guilhot J, Launey Y. et al Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial. Intensive Care Med 2015; 41: 975-984
• 13 Dellinger RP, Bagshaw SM, Antonelli M. et al Effect of Targeted Polymyxin B Hemoperfusion on 28-Day Mortality in Patients With Septic Shock and Elevated Endotoxin Level: The EUPHRATES Randomized Clinical Trial. JAMA 2018; 320: 1455-1463
• 14 Eden G, Schmidt JJ, Büttner S. et al Safety and efficacy of the Seraph^® 100 Microbind^® Affinity Blood Filter to remove bacteria from the blood stream: results of the first in human study. Crit Care 2022; 26: 181
• 15 Andermatt R, Bloemberg GV, Ganter CC. et al Elimination of Herpes Simplex Virus-2 and Epstein-Barr Virus With Seraph 100 Microbind Affinity Blood Filter and Therapeutic Plasma Exchange: An Explorative Study in a Patient With Acute Liver Failure. Crit Care Explor 2022; 04: e0745
• 16 Friesecke S, Stecher SS, Gross S. et al Extracorporeal cytokine elimination as rescue therapy in refractory septic shock: a prospective single-center study. J Artif Organs 2017; 20: 252-259
• 17 Brouwer WP, Duran S, Kuijper M, Ince C. Hemoadsorption with CytoSorb shows a decreased observed versus expected 28-day all-cause mortality in ICU patients with septic shock: a propensity-score-weighted retrospective study. Crit Care 2019; 23: 317
• 18 Wendel Garcia PD, Hilty MP, Held U. et al Cytokine adsorption in severe, refractory septic shock. Intensive Care Med 2021; 47: 1334-1336
• 19 Becker S, Lang H, Vollmer Barbosa C. et al Efficacy of CytoSorb^®: a systematic review and meta-analysis. Crit Care 2023; 27: 215
• 20 Rimmer E, Houston BL, Kumar A. et al The efficacy and safety of plasma exchange in patients with sepsis and septic shock: a systematic review and meta-analysis. Crit Care 2014; 18: 699
• 21 Knaup H, Stahl K, Schmidt BMW. et al Early therapeutic plasma exchange in septic shock: a prospective open-label nonrandomized pilot study focusing on safety, hemodynamics, vascular barrier function, and biologic markers. Crit Care 2018; 22: 285
• 22 David S, Bode C, Putensen C. et al EXCHANGE study group. Adjuvant therapeutic plasma exchange in septic shock. Intensive Care Med 2021; 47: 352-354
• 23 David S, Bode C, Stahl K. EXCHANGE-2 Study group. EXCHANGE-2: investigating the efficacy of add-on plasma exchange as an adjunctive strategy against septic shock-a study protocol for a randomized, prospective, multicenter, open-label, controlled, parallel-group trial. Trials 2023; 24: 277
• 24 Bosch X, Poch E, Grau JM. Rhabdomyolysis and acute kidney injury. N Engl J Med 2009; 361: 62-72
• 25 Albrecht F, Schunk S, Fuchs M. et al Rapid and Effective Elimination of Myoglobin with CytoSorb^® Hemoadsorber in Patients with Severe Rhabdomyolysis. Blood Purif 2024; 53: 88-95
• 26 Gräfe C, Liebchen U, Greimel A. et al The effect of cytosorb^® application on kidney recovery in critically ill patients with severe rhabdomyolysis: a propensity score matching analysis. Ren Fail 2023; 45: 2259231
• 27 Huber W, Ruiz de Garibay AP. Options in extracorporeal support of multiple organ failure. Med Klin Intensivmed Notfmed 2020; 115 (Suppl. 01) 28-36
• 28 Thompson Bastin ML, Stromberg AJ, Nerusu SN. et al Association of Phosphate-Containing versus Phosphate-Free Solutions on Ventilator Days in Patients Requiring Continuous Kidney Replacement Therapy. Clin J Am Soc Nephrol 2022; 17: 634-642
• 29 Wallon G, Guth C, Guichon C. et al Extracorporeal Albumin Dialysis in Liver Failure with MARS and SPAD: A Randomized Crossover Trial. Blood Purif 2022; 51: 243-250
• 30 Sauer IM, Goetz M, Steffen I. et al In vitro comparison of the molecular adsorbent recirculation system (MARS) and single-pass albumin dialysis (SPAD). Hepatology 2004; 39: 1408-1414
• 31 Mitzner SR, Stange J, Klammt S. et al Albumin dialysis MARS: knowledge from 10 years of clinical investigation. ASAIO J 2009; 55: 498-502
• 32 Huber W, Lorenz G, Heilmaier M. et al Extracorporeal multiorgan support including CO 2 -removal with the ADVanced Organ Support (ADVOS) system for COVID-19: A case report. Int J Artif Organs 2021; 44: 288-294
• 33 Larsen FS, Schmidt LE, Bernsmeier C. et al High-volume plasma exchange in patients with acute liver failure: An open randomised controlled trial. J Hepatol 2016; 64: 69-78
• 34 Calabrò MG, Febres D, Recca G. et al Blood Purification With CytoSorb in Critically Ill Patients: Single-Center Preliminary Experience. Artif Organs 2019; 43: 189-194
• 35 Scharf C, Liebchen U, Paal M. et al Successful elimination of bilirubin in critically ill patients with acute liver dysfunction using a cytokine adsorber and albumin dialysis: a pilot study. Sci Rep 2021; 11: 10190
• 36 Saliba F, Bañares R, Larsen FS. et al Artificial liver support in patients with liver failure: a modified DELPHI consensus of international experts. Intensive Care Med 2022; 48: 1352-1367
• 37 Falkensteiner C, Kortgen A, Leonhardt J. et al Comparison of albumin dialysis devices molecular adsorbent recirculating system and ADVANCED Organ Support system in critically ill patients with liver failure—A retrospective analysis. Ther Apher Dial 2021; 25: 225-236
• 38 Kortgen A, Rauchfuss F, Götz M. et al Albumin Dialysis in Liver Failure: Comparison of Molecular Adsorbent Recirculating System and Single Pass Albumin Dialysis--A Retrospective Analysis. Ther Apher Dial 2009; 13: 419-425
• 39 Fuhrmann V, Perez Ruiz De Garibay A, Faltlhauser A. et al Registry on extracorporeal multiple organ support with the advanced organ support (ADVOS) system: 2-year interim analysis. Medicine (Baltimore) 2021; 100: e24653 al. Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study. Crit Care 2015; 19: 349
• 40 Schneider AG, Journois D, Rimmelé T. Complications of regional citrate anticoagulation: accumulation or overload?. Crit Care 2017; 21: 281
• 41 Husain-Syed F, Emlet DR, Wilhelm J. et al Effects of preoperative high-oral protein loading on short- and long-term renal outcomes following cardiac surgery: a cohort study. J Transl Med 2022; 20: 204
• 42 Worku B, Khin S, Gaudino M. et al Renal replacement therapy in patients on extracorporeal membrane oxygenation support: Who and how. Int J Artif Organs 2021; 44: 531-538
• 43 Schmidt M, Jaber S, Zogheib E. et al Feasibility and safety of low-flow extracorporeal CO2 removal managed with a renal replacement platform to enhance lung-protective ventilation of patients with mild-to-moderate ARDS. Crit Care 2018; 22: 122
• 44 Nentwich J, Wichmann D, Kluge S. et al Low-flow CO2 removal in combination with renal replacement therapy effectively reduces ventilation requirements in hypercapnic patients: a pilot study. Ann Intensive Care 2019; 09: 3
• 45 Allescher J, Rasch S, Wiessner JR. et al Extracorporeal carbon dioxide removal with the Advanced Organ Support system in critically ill COVID-19 patients. Artif Organs 2021; 45: 1522-1532